Physician profile
Colleen A Johnson
NPI 1932490083
$17,291.18
in general payments reported to CMS, 2019-2025
60 companies · $3,612 in 2025
The $3,612 reported for 2025 was more than what 96% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,883 · 2022: $4,017 · 2023: $3,127 · 2024: $3,653 · 2025: $3,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,016.07 |
| Education | $375.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,732.64 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $1,232.43 | 2021-2025 | Ultomiris, Soliris |
| Jazz Pharmaceuticals INC. | $1,100.22 | 2021-2025 | |
| Ucb, INC. | $967.15 | 2021-2025 | Briviact, Nayzilam, Fintepla |
| Sk Life Science, INC. | $879.44 | 2021-2025 | Xcopri |
| Neurocrine Biosciences, INC. | $857.01 | 2021-2025 | Ingrezza, Ongentys |
| Harmony Biosciences LLC | $709.09 | 2022-2025 | Wakix |
| Novartis Pharmaceuticals Corporation | $702.05 | 2021-2025 | |
| Genentech USA, INC. | $648.26 | 2021-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Biogen, INC. | $624.27 | 2021-2025 | Tysabri, Vumerity, Skyclarys |
| Emd Serono, INC. | $576.10 | 2021-2025 | |
| Genzyme Corporation | $497.52 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $478.88 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Eisai INC. | $472.32 | 2022-2025 | |
| Amgen INC. | $463.23 | 2021-2024 | Aimovig, Uplizna |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.